U.S. Bankruptcy Judge Kevin Gross on Thursday ruled in favor of the $55 million sale of Hahnemann University Hospital's residency program to a coalition of six health systems, in today's bite-sized hospital and health industry news from Kentucky, Massachusetts, and Ohio.
While medication-assisted treatment is considered "the gold standard" for managing opioid misuse disorder, most state programs for health care professionals seeking to recover from opioid use often deny access to these medications, Selena Simmons-Duffin reports for NPR's "Shots."
Public health officials on Friday reported more deaths likely caused by a lung illness tied to e-cigarette use and vaping, as federal health agencies issued conflicting warnings about vaping and e-cigarette use.
Major insurers are developing new strategies to help employers cover the cost of multimillion-dollar gene therapies—approaches that "may signal the beginning of a fundamental shift in how payers and employers approach ultra-high-cost treatments," writes Advisory Board's Brandi Greenberg and Natalie Trebes.
As the debate around health care prices continues, some providers are turning to Groupon to get new patients in the door with deals on health care services—a trend that has persisted despite the industry's efforts to move away from volume-driven care.
Physician groups for years have sought to curb rates of unnecessary imaging, but these rates are still on the rise, according to a study published Tuesday in JAMA.
Drinking soft drinks every day, including sugar-free diet sodas, is associated with a greater risk of premature death, according to a study of over 450,000 people published Tuesday in JAMA Internal Medicine—although some experts say the debate over diet sodas' safety is far from over.
